Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthyinfants and toddlers in Spain
Javier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, Francisco Gimenez-Sanchez, Federico Martinon-Torres, Valentin Pineda-Solas, Alfonso Delgado, Pilar Infante-Marquez, John Z. Liang, Peter C. Giardina, William C. Gruber, Emilio A. Emini, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
THE NEVER ENDING STORY OF CORTICOSTEROIDS IN ACUTE BRONCHIOLITIS
Martinón-Torres F, Montero-Martín M.
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Year:
2013
Doi:
Noninvasive ventilation with helium-oxygen in children
Federico Martinón Torres
Journal:
J. Crit Care
Publicación independiente
Impact factor
2.685
Q3
Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin
Gabriela Rüger, Giovanni Gabutti, Hans Rümke, Lars Rombo, Enrique Bernaola, MD,|| Javier Diez-Domingo, Federico Martinon-Torres, Birthe Høgh, Antreas Konstantopoulos, Anne Fiquet, Stéphane Thomas, Cécile Eymin and Martine Baudin,
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q1
A reverse evidence of rotavirus vaccines impact.
Federico Martinón-Torres, Angela Aramburo, Nazareth Martinón-Torres, Miriam Cebey, María Teresa Seoane-Pillado, Lorenzo Redondo-Collazo and Jose Maria Martinón-Sánchez
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Management of acute bronchiolitis in emergency wards in Spain: variability and appropriateness analysis (Abreviado project)
Ochoa Sangrador C, González de Dios J; Research Group of the aBREVIADo Project (Bronchiolitis--Study of Variability, Adequacy, and Adherence) (Martinón –Torres F).
Journal:
European J of Ped.
Publicación independiente
Impact factor
2.126
Q2
Year:
2012
Doi:
Pleural antigen assay in the diagnosis of pediatric pneumococcal empyema
Federico Martinón-Torres, Silvia Dosil-Gallardo, María Luisa Perez del Molino-Bernal, Fernanda Pardo Sánchez , David Tarrago, Fernando Alvez, Sonia Pertega Diaz, Nazareth Martinón-Torres, Jose Maria Martinon Sanchez
Journal:
J. Crit Care
Publicación independiente
Impact factor
2.685
Q3
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.
Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators.
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine Study Group.
Journal:
JAMA
Publicación independiente
Impact factor
45.540
Q1
Year:
2012
Doi:
Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.
Federico Martinón-Torres, Nazareth Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Sonia Pértega-Díaz, María Teresa Seoane-Pillado, Jorge Aboal Viñas & María San-Martín
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Federico Martinón-Torres, Francisco Gimenez-Sanchez, Alejandra Gurtman, Enrique Bernaola, Javier Diez-Domingo, Alfonso Carmona, Mohinder Sidhu, Denise A. Sarkozy, William C. Gruber, Emilio A. Emini, and Daniel A. Scott, on behalf of the 3007 Study Group
Journal:
Pediatr Inf Dis J
Publicación independiente
Impact factor
2.126
Q2
Mechanical ventilation in pediatric intensive care units during the season for acute lower respiratory infection: a multicenter study.
Farias JA, Fernández A, Monteverde E, Flores JC, Baltodano A, Menchaca A, Poterala R, Pánico F, Johnson M, von Dessauer B, Donoso A, Zavala I, Zavala C, Troster E, Peña Y, Flamenco C, Almeida H, Nilda V, Esteban A; Latin-American Group for Mechanical Ventilation in Children (Martinón-Torres F).
Journal:
Pediatr Crit Care Med
Publicación independiente
Impact factor
2.854
Q1
Year:
2012
Doi:
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine
Gimenez-Sanchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Diez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, Liang JZ, Gruber WC, Emini EA, Scott DA; 501 and 006 study groups.
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Vacuna universal frente a meningococo B
Carmen Rodríguez-Tenreiro, Federico Martinón-Torres
Journal:
An Pediatr Contin
Publicación independiente
Impact factor
1.313
Q4
Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study
Bouzón-Alejandro M, Redondo-Collazo L, Sánchez-Lastres JM, Martinón-Torres N, Martinón-Sánchez JM, Martinón-Torres F; ROTACOST research team
Journal:
BMC Pediatrics
Publicación independiente
Impact factor
1.909
Q2
Effectiveness of rotavirus vaccination in Spain.
Federico Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Juan Manuel Sánchez Lastres, Sonia Pértega Díaz, Mª Teresa Seoane Pillado & José María Martinón Sánchez
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Considerations on the clinical application of the human papillomavirus vaccine in Spain
Javier Cortés, Federico Martinon-Torres, José Manuel Ramón, Cajal, Gabriel Ferret and Angel Gil
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain
Marta Bouzón Alejandro, Javier Diez Domingo and Federico Martinón Torres
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett; Elie Azoulay; Pablo M. Echeverria; Jean-Louis Vincent; and for the Extended Prevalence of Infection in the ICU Study (EPIC II) Group of Investigators (F. Martinón-Torres)
Journal:
Crit Care Med.
Publicación independiente
Impact factor
7.414
Q1
Year:
2011
Doi:
Acute lung injury in children: Therapeutic practice and feasibility of international clinical trials
Santschi M, Jouvet P, Leclerc F, Gauvin F, Newth CJ, Carroll CL, Flori H, Tasker RC, Rimensberger PC, Randolph AG; for the PALIVE Investigators, the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI); the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) (Martinón-Torres F).
Journal:
Ped Crit Care Med
Publicación independiente
Impact factor
2.854
Q1
Year:
2010
Doi:
The Spanish human papillomavirus vaccine consensus group: A working model
Javier Cortés & Federico Martinón-Torres; Spanish HPV Vaccine Consensus Group.
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain
Gimenez-Sanchez F, Delgado-Rubio A, Martinon-Torres F, Bernaola-Iturbe E; Rotascore Research Group.
Journal:
Acta Pediatr
Publicación independiente
Impact factor
2.111
Q1
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease
Davila S, Wright VJ, Khor CC, Sim KS, Binder A, Breunis WB, Inwald D, Nadel S, Betts H, Carrol ED, de Groot R, Hermans PW, Hazelzet J, Emonts M, Lim CC, Kuijpers TW, Martinon-Torres F, Salas A, Zenz W, Levin M, Hibberd ML; International Meningococcal Genetics Consortium.
Journal:
Nature Genetics
Publicación independiente
Impact factor
27.603
Q1
Estudio de variabilidad en el abordaje de la bronquiolitis aguda en España en relación con la edad de los pacientes
J. González de Dios, C. Ochoa Sangrador, Grupo Investigador del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad, ADecuación) (F. Martinón-Torres)
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Year:
2010
Doi:
No results found.
CHARACTERISTICS AND MANAGEMENT OF ADOLESCENTS ATTENDING THE ED WITH FEVER: A PROSPECTIVE MULTICENTRE STUDY
Borensztajn D, Hagedoorn NN, Carrol E, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon Torres F, Nijman R, Pokorn M, Rivero-Calle I, Tsolia M, Vermont C, Zavadska D, Zenz W, Zachariasse J, Moll HA; PERFORM Consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union.
Doi:
BMJ Open
Factor de impacto:
Q2
Doi:
EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS
Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V
Doi:
Pathog Glob Health
Factor de impacto:
Q2
Doi:
IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)
Cook A, Sharland M, Yau Y; PediBSI Group*, Bielicki J. (Martinón-Torres F)
Doi:
Expert Rev Anti Infect Ther.
Factor de impacto:
Q1
Doi:
SHOCK INDEX IN THE EARLY ASSESSMENT OF FEBRILE CHILDREN AT THE EMERGENCY
Hagedoorn NN, Zachariasse JM, Borensztajn D, Adriaansens E, von Both U, Carrol ED, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA; PERFORM consortium
Doi:
Arch Dis Child
Factor de impacto:
Q1
Doi:
NIRSEVIMAB FOR PREVENTION OF RSV IN HEALTHY LATE-PRETERM AND TERM INFANTS
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group (Martinón-Torres F)
Doi:
N Engl J Med
Factor de impacto:
Q1
Doi:
VESICULOBULLOUS SKIN REACTIONS INDUCED BY COVID-19 MRNA VACCINE: REPORT OF FOUR CASES AND REVIEW OF THE LITERATURE
Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F
Doi:
Clin Exp Dermatol
Factor de impacto:
Q2
Doi:
EVALUATION OF THE BNT162B2 COVID-19 VACCINE IN CHILDREN 5 TO 11 YEARS OF AGE
Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. (Martinón-Torres F)
Doi:
N Engl J Med
Factor de impacto:
Q1
Doi:
CORRIGENDUM: CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEOUS HETEROPLASIA
Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
Doi:
Front Pediatr
Factor de impacto:
Q1
Doi:
EARLY IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ON PEDIATRIC CLINICAL RESEARCH: A PAN-EUROPEAN AND CANADIAN SNAPSHOT IN TIME.
Mantha OL, Flamein F, Turner MA, Fernandes RM, Hankard R; Network of National Networks Study Group. (Martinón-Torres F)
Doi:
J Pediatr
Factor de impacto:
Q1
Doi:
SIMULTANEOUS VIRAL WHOLE-GENOME SEQUENCING AND DIFFERENTIAL EXPRESSION PROFILING IN RESPIRATORY SYNCYTIAL VIRUS INFECTION OF INFANTS
Gu-Lung Lin, Tanya Golubchik, Simon Drysdale, Daniel O’Connor, Kimberley Jefferies, Anthony Brown, Mariateresa de Cesare, David Bonsall, M. Azim Ansari, Jeroen Aerssens, Louis Bont, Peter Openshaw, Federico Martinón-Torres, Rory Bowden, and Andrew J. Pollard; the RESCEU Investigators
The Journal of Infectious Diseases
Factor de impacto:
Q1
Doi:
IDENTIFICATION OF NOVEL RISK LOCI AND CAUSAL INSIGHTS FOR SPORADIC CREUTZFELDT-JAKOB DISEASE: A GENOME-WIDE ASSOCIATION STUDY
Emma Jones, Holger Hummerich, Emmanuelle Viré, James Uphill, Athanasios Dimitriadis, Helen Speedy, Tracy Campbell, Penny Norsworthy, Liam Quinn, Jerome Whitfield, Jacqueline Linehan, Zane Jaunmuktane, Sebastian Brandner, Parmjit Jat, Akin Nihat, Tze How Mok, Parvin Ahmed, Steven Collins, Christiane Stehmann, Shannon Sarros, Gabor G Kovacs, Michael D Geschwind, Aili Golubjatnikov, Karl Frontzek, Herbert Budka, Adriano Aguzzi, Hata Karamujić-Čomić, Sven J van der Lee, Carla A Ibrahim-Verbaas, Cornelia M Van Duijn, Beata Sikorska, Ewa Golanska, Pawel Liberski, Miguel Calero, Olga Calero, Pascual Sanchez-Juan, Antonio Salas, Federico Martinón-Torres, Elodie Bouaziz-Amar, Stephane Haik, Jean-Louis Laplanche, Jean-Phillipe Brandel, Phillipe Amouyel, Jean-Charles Lambert, Piero Parchi, Anna Bartoletti-Stella, Sabina Capellari, Anna Poleggi, Anna Ladogana, Maurizio Pocchiari, Serena Aneli, Giuseppe Matullo, Richard Knight, Saima Zafar, Inga Zerr, Stephanie Booth, Michael B Coulthart, Gerard H Jansen, Katie Glisic, Janis Blevins, Pierluigi Gambetti, Jiri Safar, Brian Appleby, John Collinge, Simon Mead
Factor de impacto:
Doi:
SEROPREVALENCE OF SARS-COV-2 AMONG PEDIATRIC HEALTHCARE WORKERS IN SPAIN
Ana Dacosta-Urbieta, Irene Rivero-Calle, Jacobo Pardo-Seco, Lorenzo Redondo-Collazo, Antonio Salas, Jose Gómez-Rial and Federico Martinón-Torres
Factor de impacto:
Doi:
ROLE OF MONOCYTES/MACROPHAGES IN COVID-19 PATHOGENESIS: IMPLICATIONS FOR THERAPY.
Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F.
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU) BIRTH COHORT STUDY: DEFINING THE BURDEN OF INFANT RESPIRATORY SYNCYTIAL VIRUS DISEASE IN EUROPE
Joanne G Wildenbeest, Roy P Zuurbier, Koos Korten, Marlies A van Houten, Marie N Billard, Nicole Derksen-Lazet, Matthew D Snape, Simon B Drysdale, Hannah Robinson, Andrew J Pollard, Terho Heikkinen, Steve Cunningham, Amanda Leach, Federico Martinón-Torres, Carmen Rodríguez-Tenreiro Sánchez, Alberto Gómez-Carballa, Louis J Bont, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
PRESUMED RISK FACTORS AND BIOMARKERS FOR SEVERE RESPIRATORY SYNCYTIAL VIRUS DISEASE AND RELATED SEQUELAE: PROTOCOL FOR AN OBSERVATIONAL MULTICENTER, CASE-CONTROL STUDY FROM THE RESPIRATORY SYNCYTIAL VIRUS CONSORTIUM IN EUROPE (RESCEU)
Kimberley Jefferies, Simon B Drysdale, Hannah Robinson, Elizabeth Ann Clutterbuck, Luke Blackwell, Joseph McGinley, Gu-Lung Lin, Ushma Galal, Harish Nair, Jeroen Aerssens, Deniz Öner, Annefleur Langedijk, Louis Bont, Joanne G Wildenbeest, Federico Martinon-Torres, Carmen Rodríguez-Tenreiro Sánchez, Simon Nadel, Peter Openshaw, Ryan Thwaites, Myra Widjojoatmodjo, Linong Zhang, Thi Lien-Anh Nguyen, Carlo Giaquinto, Giuseppe Giordano, Eugenio Baraldi, Andrew J Pollard, Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
Factor de impacto:
Doi:
BIOMARKERS FOR DISEASE SEVERITY IN CHILDREN INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS: A SYSTEMATIC LITERATURE REVIEW
Öner D, Drysdale SB, McPherson C, Lin GL, Janet S, Broad J, Pollard AJ, Aerssens J; RESCEU Investigators (F Martinón-Torres)
Factor de impacto:
Doi:
BIOMARKERS FOR THE DISCRIMINATION OF ACUTE KAWASAKI DISEASE FROM INFECTIONS IN CHILDHOOD
Judith Zandstra, Annemarie van de Geer, Michael W T Tanck, Diana van Stijn-Bringas, Dimitriades, Cathelijn E M Aarts, Sanne M Dietz, Robin van Bruggen, Nina A Schweintzger, Werner Zenz, Marieke Emonts, Dace Zavadska, Marko Pokorn, Effua Usuf, Henriette A Moll, Luregn J Schlapbach, Enitan D Carrol, Stephane Paulus, Maria Tsolia, Colin Fink, Shunmay Yeung, Chisato Shimizu, Adriana Tremoulet, Rachel Galassini, Victoria J Wright, Federico Martinón-Torres, Jethro Herberg, Jane Burns, Michael Levin, Taco W Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
Factor de impacto:
Doi:
SINGLE-DOSE NIRSEVIMAB FOR PREVENTION OF RSV IN PRETERM INFANTS
M. Pamela Griffin, Yuan Yuan, Therese Takas, Joseph B. Domachowske, Shabir A. Madhi, Paolo Manzoni, Eric A.F. Simões, Mark T. Esser, Anis A. Khan, Filip Dubovsky, Tonya Villafana and John P. DeVincenzo for the Nirsevimab Study Group*(Federico Martinón Torres)
Factor de impacto:
Doi:
RESPIRATORY SYNCYTIAL VIRUS VACCINATION DURING PREGNANCY AND EFFECTS IN INFANTS
S.A. Madhi, F.P. Polack, P.A. Piedra, F.M. Munoz, A.A. Trenholme, E.A.F. Simões, G.K. Swamy, S. Agrawal, K. Ahmed, A. August, A.H. Baqui, A. Calvert, J. Chen, I. Cho, M.F. Cotton, C.L. Cutland, J.A. Englund, A. Fix, B. Gonik, L. Hammitt, P.T. Heath, J.N. de Jesus, C.E. Jones, A. Khalil, D.W. Kimberlin, R. Libster, C.J. Llapur, M. Lucero, G. Pérez Marc, H.S. Marshall, M.S. Masenya,F. Martinón‐Torres, J.K. Meece, T.M. Nolan, A. Osman, K.P. Perrett, J.S. Plested, P.C. Richmond, M.D. Snape, J.H. Shakib, V. Shinde, T. Stoney, D.N. Thomas, A.T. Tita, M.W. Varner, M. Vatish, K. Vrbicky, J. Wen, K. Zaman, H.J. Zar, G.M. Glenn, and L.F. Fries, for the Prepare Study Group*
Factor de impacto:
Doi: